Zhenzi Peng

1.3k total citations
24 papers, 829 citations indexed

About

Zhenzi Peng is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Zhenzi Peng has authored 24 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Cancer Research. Recurrent topics in Zhenzi Peng's work include Cancer-related molecular mechanisms research (8 papers), Renin-Angiotensin System Studies (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). Zhenzi Peng is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Renin-Angiotensin System Studies (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). Zhenzi Peng collaborates with scholars based in China, United States and Japan. Zhenzi Peng's co-authors include Chaojun Duan, Chunfang Zhang, Yeping Dong, Weisong Shi, Dan He, Bin Shan, Wenyuan Zhao, Jun Wang, Wei Peng and Bin Li and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Zhenzi Peng

24 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenzi Peng China 13 602 453 148 109 66 24 829
Xinxing Wang China 15 673 1.1× 535 1.2× 83 0.6× 79 0.7× 64 1.0× 30 823
Marianna Penzo Italy 20 759 1.3× 321 0.7× 133 0.9× 136 1.2× 65 1.0× 39 1.1k
Bohong Cen China 11 546 0.9× 484 1.1× 102 0.7× 63 0.6× 61 0.9× 31 830
Weili Duan China 13 391 0.6× 302 0.7× 107 0.7× 70 0.6× 39 0.6× 22 657
Wenkai Ni China 19 835 1.4× 380 0.8× 180 1.2× 174 1.6× 106 1.6× 42 1.1k
Caroline Diener Germany 12 698 1.2× 562 1.2× 87 0.6× 44 0.4× 68 1.0× 17 965
Ling‐Min Kong China 14 588 1.0× 270 0.6× 136 0.9× 135 1.2× 62 0.9× 22 791

Countries citing papers authored by Zhenzi Peng

Since Specialization
Citations

This map shows the geographic impact of Zhenzi Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenzi Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenzi Peng more than expected).

Fields of papers citing papers by Zhenzi Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenzi Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenzi Peng. The network helps show where Zhenzi Peng may publish in the future.

Co-authorship network of co-authors of Zhenzi Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenzi Peng. A scholar is included among the top collaborators of Zhenzi Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenzi Peng. Zhenzi Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saito, Suguru, Alato Okuno, Zhenzi Peng, Duo‐Yao Cao, & Noriko M. Tsuji. (2024). Probiotic lactic acid bacteria promote anti-tumor immunity through enhanced major histocompatibility complex class I-restricted antigen presentation machinery in dendritic cells. Frontiers in Immunology. 15. 1335975–1335975. 9 indexed citations
2.
Peng, Zhenzi & Suguru Saito. (2023). Creatine supplementation enhances anti-tumor immunity by promoting adenosine triphosphate production in macrophages. Frontiers in Immunology. 14. 1176956–1176956. 12 indexed citations
3.
Saito, Suguru, et al.. (2022). Creatine supplementation enhances immunological function of neutrophils by increasing cellular adenosine triphosphate. Bioscience of Microbiota Food and Health. 41(4). 185–194. 11 indexed citations
4.
Saito, Suguru, et al.. (2021). RASAL3 Is a Putative RasGAP Modulating Inflammatory Response by Neutrophils. Frontiers in Immunology. 12. 744300–744300. 10 indexed citations
5.
Peng, Zhenzi, Cuiwei Liu, Aaron Victor, et al.. (2021). Tumors exploit CXCR4 hi CD62L lo aged neutrophils to facilitate metastatic spread. OncoImmunology. 10(1). 1870811–1870811. 40 indexed citations
6.
Wang, Jun, Wenyuan Zhao, Zhenzi Peng, et al.. (2020). Vasculogenic mimicry in carcinogenesis and clinical applications. Journal of Hematology & Oncology. 13(1). 19–19. 224 indexed citations
7.
Veiras, Luciana C., Duo‐Yao Cao, Suguru Saito, et al.. (2020). Overexpression of ACE in Myeloid Cells Increases Immune Effectiveness and Leads to a New Way of Considering Inflammation in Acute and Chronic Diseases. Current Hypertension Reports. 22(1). 4–4. 8 indexed citations
8.
9.
Cao, Duo‐Yao, Weston Spivia, Luciana C. Veiras, et al.. (2020). ACE overexpression in myeloid cells increases oxidative metabolism and cellular ATP. Journal of Biological Chemistry. 295(5). 1369–1384. 28 indexed citations
10.
Okwan‐Duodu, Derick, Daiana Weiss, Zhenzi Peng, et al.. (2019). Overexpression of myeloid angiotensin-converting enzyme (ACE) reduces atherosclerosis. Biochemical and Biophysical Research Communications. 520(3). 573–579. 17 indexed citations
11.
Khan, Zakir, Duo‐Yao Cao, Jorge F. Giani, et al.. (2019). Overexpression of the C-domain of angiotensin-converting enzyme reduces melanoma growth by stimulating M1 macrophage polarization. Journal of Biological Chemistry. 294(12). 4368–4380. 31 indexed citations
12.
Cao, Duo‐Yao, Weston Spivia, Luciana C. Veiras, et al.. (2019). ACE overexpression in myeloid cells increases oxidative metabolism and cellular ATP. Journal of Biological Chemistry. 295(5). 1369–1384. 32 indexed citations
13.
Peng, Wei, Dan He, Bin Shan, et al.. (2019). LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway. Cell Death and Disease. 10(7). 533–533. 39 indexed citations
14.
Peng, Wei, Jun Wang, Bin Shan, et al.. (2018). Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer. Cellular Physiology and Biochemistry. 49(2). 816–827. 40 indexed citations
15.
Wang, Shaoqiang, Yuanda Cheng, Yang Gao, et al.. (2018). SH2B1 promotes epithelial‐mesenchymal transition through the IRS1/β‐catenin signaling axis in lung adenocarcinoma. Molecular Carcinogenesis. 57(5). 640–652. 15 indexed citations
16.
Peng, Zhenzi, Jun Wang, Bin Shan, et al.. (2017). Genome-wide analyses of long noncoding RNA expression profiles in lung adenocarcinoma. Scientific Reports. 7(1). 15331–15331. 19 indexed citations
17.
Wang, Xia, Yu-Ping Peng, Jun Wang, et al.. (2017). Silencing platelet-derived growth factor receptor-β enhances the radiosensitivity of C6 glioma cells in vitro and in vivo. Oncology Letters. 14(1). 329–336. 5 indexed citations
18.
Dong, Yeping, Dan He, Zhenzi Peng, et al.. (2017). Circular RNAs in cancer: an emerging key player. Journal of Hematology & Oncology. 10(1). 2–2. 218 indexed citations
19.
Duan, Chaojun, Chunfang Zhang, & Zhenzi Peng. (2016). Functions and mechanisms of long noncoding RNAs in lung cancer. OncoTargets and Therapy. Volume 9. 4411–4424. 38 indexed citations
20.
Wang, Jun, Zhenzi Peng, Yeping Dong, et al.. (2016). [Expression of two transcript variants of long noncoding RNA C6orf176 in non-small cell lung cancer and its clinical significance].. PubMed. 41(6). 560–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinxing Wang Breakdown of academic impact, for papers by Marianna Penzo Breakdown of academic impact, for papers by Bohong Cen Breakdown of academic impact, for papers by Weili Duan Breakdown of academic impact, for papers by Wenkai Ni Breakdown of academic impact, for papers by Caroline Diener Breakdown of academic impact, for papers by Ling‐Min Kong
Rankless by CCL
2026